CIK 0001815442
- Large accelerated filer
Kymera Therapeutics, Inc.
Sign in to watch- Ticker
- KYMR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812992166
- Phone
- +1 857-285-5314
- Business address
- 500 NORTH BEACON STREET, 4TH FLOOR, WATERTOWN, MA, 02472
- Former names
- Kymera Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,158,214
- in 2 filings, $3.4M under 10b5-1 plans
Net −$4,158,214. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 68 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-10-17 | Mainolfi Nello Chief Executive Officer | Exercise or conversion | +27,676 | $2.08 | $58K | 561,931 |
| 2022-10-17 | Mainolfi Nello Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) | −32,056 | 14,368 | ||
| 2022-10-17 | Mainolfi Nello Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) | −27,676 | 546,604 | ||
| 2022-08-22 | BVF PARTNERS L P/IL Director | Purchase | +285,046 | $26.00 | $7.4M | 2,480,742 |
| 2022-08-22 | BVF PARTNERS L P/IL Director | Purchase | +233,362 | $26.00 | $6.1M | 1,861,290 |
| 2022-08-22 | BVF PARTNERS L P/IL Director | Purchase | +27,117 | $26.00 | $705K | 257,754 |
| 2022-07-06 | Morgan Leigh Director | Grant or award · Stock Option (Right to Buy) | +24,000 | 24,000 | ||
| 2022-06-29 | Ridloff Elena Director | Grant or award · Stock Option (Right to Buy) | +9,000 | 9,000 | ||
| 2022-06-15 | BVF PARTNERS L P/IL Director | Grant or award · Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2022-06-15 | Hrustanovic Gorjan Director | Grant or award · Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2022-06-15 | Nicholson Donald William Director | Grant or award · Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2022-06-15 | Esposito Pamela Director | Grant or award · Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2022-06-15 | Ridloff Elena Director | Grant or award · Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2022-06-15 | Booth Bruce Director | Grant or award · Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2022-06-15 | Albers Jeffrey W. Director | Grant or award · Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2022-06-15 | Horobin Joanna Director | Grant or award · Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2022-05-27 | BVF PARTNERS L P/IL Director | Purchase | +35,793 | $14.78 | $529K | 2,195,696 |
| 2022-05-27 | BVF PARTNERS L P/IL Director | Purchase | +26,353 | $14.78 | $390K | 1,627,928 |
| 2022-05-27 | BVF PARTNERS L P/IL Director | Purchase | +3,223 | $14.78 | $48K | 230,637 |
| 2022-05-26 | BVF PARTNERS L P/IL Director | Purchase | +123,043 | $14.21 | $1.7M | 2,159,903 |
Page 37 of 41 · 810 trades